Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Bevirimat in HIV-1 Positive Patients
NCT01097070Phase 2Completed
- Sponsor
- Myrexis, Inc.
- Start
- Nov 2008
- Primary completion
- Jan 2009
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bevirimat in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Myrexis, Inc.. Started Nov 2008; status: completed.
02
Drugs
bevirimat
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01097070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01097070.